基于铜死亡相关长链非编码RNA构建膀胱癌患者预后风险评估模型
暂无分享,去创建一个
[1] Yilin Yan,et al. A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer , 2023, Frontiers in Genetics.
[2] Chiyu Zhang,et al. Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer , 2022, Scientific reports.
[3] Ling-fang He,et al. A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer , 2022, Frontiers in Oncology.
[4] Jingchao Liu,et al. Ferroptosis-Related Long Noncoding RNAs Have Excellent Predictive Ability for Multiomic Characteristics of Bladder Cancer , 2022, Oxidative medicine and cellular longevity.
[5] Xianwei Zhang,et al. A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma , 2022, Scientific Reports.
[6] Lingmin Xie,et al. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma , 2022, Genes.
[7] T. Golub,et al. Copper induces cell death by targeting lipoylated TCA cycle proteins , 2022, Science.
[8] Huibiao Quan,et al. Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes , 2022, Frontiers in Endocrinology.
[9] Wenzhou Zhang,et al. Comprehensive analysis of cuproptosis-related lncRNAs in the prognosis and therapy response of patients with bladder cancer , 2022, Annals of translational medicine.
[10] Tao Zhou,et al. A Newly Defined Pyroptosis-Related Gene Signature for the Prognosis of Bladder Cancer , 2021, International journal of general medicine.
[11] J. Kładny,et al. Blood Copper Levels and the Occurrence of Colorectal Cancer in Poland , 2021, Biomedicines.
[12] Jianyi(Jay) Zhang,et al. A Novel Human Long Noncoding RNA SCDAL Promotes Angiogenesis through SNF5‐Mediated GDF6 Expression , 2021, Advanced science.
[13] M. Z. Rahman,et al. Significance of Vascular Endothelial Growth Factor Expression in the Bladder Urothelial Carcinoma and Its Association with Tumor Grade and Invasiveness , 2021, Iranian journal of pathology.
[14] R. Zheng,et al. [Bladder cancer incidence, mortality and temporal trends in China]. , 2021, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[15] Haiyong Wang,et al. Immune-Related Long Non-coding RNA Signature and Clinical Nomogram to Evaluate Survival of Patients Suffering Esophageal Squamous Cell Carcinoma , 2021, Frontiers in Cell and Developmental Biology.
[16] W. Li,et al. Re-evaluating the need for mediastinal lymph node dissection and exploring lncRNAs as biomarkers of N2 metastasis in T1 lung adenocarcinoma , 2021, Translational lung cancer research.
[17] R. Iozzo,et al. Progranulin/EphA2 axis: A novel oncogenic mechanism in bladder cancer. , 2020, Matrix biology : journal of the International Society for Matrix Biology.
[18] V. Darley-Usmar,et al. Lung Tumor Cell-Derived Exosomes Promote M2 Macrophage Polarization , 2020, Cells.
[19] Bo Zhou,et al. A hydrogen peroxide-activated Cu(II) pro-ionophore strategy for modifying naphthazarin as a promising anticancer agent with high selectivity for generating ROS in HepG2 cells over in L02 cells. , 2019, Free radical biology & medicine.
[20] Hong Wang,et al. [Preoperative Lymphocyte-to-monocyte Ratio Predicts Prognosis in Patients with Stage T1 Non-muscle Invasive Bladder Cancer]. , 2019, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae.
[21] D. Feldser,et al. Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma , 2019, bioRxiv.
[22] K. Jirström,et al. Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens , 2019, Oncoimmunology.
[23] Yueqin Liu,et al. The role of differential expressed long non-coding RNA in breast cancer , 2019 .
[24] A. Piwowar,et al. Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer , 2019, Pathology & Oncology Research.
[25] T. Powles,et al. The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer. , 2019, European urology.
[26] I. Sagap,et al. LOC285629 regulates cell proliferation and motility in colorectal cancer cells , 2018, Clinical and Translational Oncology.
[27] I. Shabo,et al. M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer. , 2017, Urologic oncology.
[28] C. Counter,et al. Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors. , 2017, Cancer research.
[29] Sam S. Chang. Re: EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. , 2017, The Journal of urology.
[30] Q Ping Dou,et al. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. , 2006, Cancer research.
[31] Daniel F. Brayton,et al. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. , 2004, Journal of medicinal chemistry.
[32] L. Collette,et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. , 2016, European urology.